文献速递前列腺增生与排尿功能障碍男科与性医学

「骨盆疼痛图」的验证:一种用于慢性骨盆疼痛定位的新自评工具

Validation of the 'Pelvic Pain Map': a new self-assessment tool for chronic pelvic pain localisation.
PubMed 文献 · BJU Int · 2023-03-23

本研究开发并验证了骨盆疼痛图,一种用于慢性骨盆疼痛定位的自评身体图。该图纳入12名美国慢性骨盆疼痛专家意见及患者反馈评估表面效度,并在2022年1月至5月完成该图的慢性骨盆疼痛综合征回顾性队列中评估重测信度与结构效度。结果显示各图区重测信度为中等至优秀(Cohen's kappa系数0.28至0.64),总图区组内相关系数为0.90;与泌尿生殖疼痛指数位置描述符的聚合效度强(phi系数0.26至0.79),总图区聚合效度中等(Spearman相关系数0.56),区分效度弱阳性(Spearman相关系数0.27至0.32)。结论提示骨盆疼痛图是评估慢性骨盆疼痛综合征患者疼痛位置的有效可靠工具。

要点

  • 骨盆疼痛图整合12名美国专家意见与患者反馈,含男女性骨盆单幅正面图。
  • 各图区重测信度Cohen's kappa系数0.28至0.64,总图区组内相关系数0.90。
  • 与泌尿生殖疼痛指数位置描述符聚合效度强,phi系数0.26至0.79。

核心结论

  • 本研究提示骨盆疼痛图是评估慢性骨盆疼痛综合征患者疼痛位置的有效可靠工具。
  • 研究结果凸显骨盆疼痛图在指导治疗选择和监测慢性骨盆疼痛患者治疗反应方面的潜在效用。

研究设计与样本

  • 骨盆疼痛图纳入12名美国慢性骨盆疼痛专家的意见及患者反馈以评估表面效度。
  • 最终图为男性和女性骨盆的单幅正面图像,包含腹部和会阴视图。
  • 在2022年1月至2022年5月完成该图的慢性骨盆疼痛综合征患者回顾性队列中评估重测信度和结构效度(聚合效度和区分效度)。
  • 验证过程使用的其他测量工具包括男性和女性版泌尿生殖疼痛指数(GUPI)以及疼痛灾难化量表六条目简版(PCS-6)。

主要发现

  • 各图区重测信度为中等至优秀,Cohen's kappa系数范围为0.28至0.64。
  • 总图区重测信度为优秀,组内相关系数为0.90。
  • 各图区与GUPI位置描述符的聚合效度强,phi系数范围为0.26至0.79。
  • 总图区聚合效度中等,Spearman相关系数为0.56。
  • 总图区与GUPI和PCS-6中独立但相关构念的区分效度为弱阳性,Spearman相关系数范围为0.27至0.32。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop and validate the Pelvic Pain Map to fill a gap in the need for a localised body map of the pelvic region. PATIENTS AND METHODS: The Pelvic Pain Map incorporated input from 12 chronic pelvic pain experts across the United States, as well as patient feedback to assess face validity. Finalised diagrams are single, front-facing images of the male and female pelvis that incorporate both abdominal and perineal views. Assessment of test-retest reliability and construct (convergent and discriminant) validity was carried out on a retrospective cohort of patients with chronic pelvic pain syndrome (CPPS) who completed the maps from January 2022 to May 2022. Other measures used in the validation process consisted of the male and female forms of the Genitourinary Pain Index (GUPI) and the short form (six item) of the Pain Catastrophising Scale (PCS-6). RESULTS: Test-retest for individual map zones demonstrated moderate to excellent reliability (Cohen's kappa coefficients ranging from 0.28 to 0.64) and for total map zones demonstrated excellent reliability (intraclass correlation coefficient = 0.90). Convergent validity for individual map zones with location descriptors from the GUPI was strong (phi coefficients ranging from 0.26 to 0.79) and for total map zones was moderate (Spearman's correlation coefficient = 0.56). Discriminant validity for total map zones with separate, but related constructs from the GUPI and PCS-6 was weakly positive (Spearman's correlation coefficients ranging from 0.27 to 0.32). CONCLUSION: This study suggests that the Pelvic Pain Map is a valid and reliable tool for assessing location of pain in patients with CPPS. Our findings highlight the potential utility of the Pelvic Pain Map in guiding treatment selection and monitoring therapeutic response in patients with chronic pelvic pain.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Aibel K, Moldwin R. Validation of the 'Pelvic Pain Map': a new self-assessment tool for chronic pelvic pain localisation. BJU Int. 2023. PMID: 36722397. doi:10.1111/bju.15979

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。